Costimulatory molecules and cytotoxic T cells in chronic hepatitis C: Defence mechanisms devoted to host integrity or harmful events favouring liver injury progression? A review

被引:12
作者
Antonaci, S [1 ]
Schiraldi, O [1 ]
机构
[1] Univ Bari Policlin, Dipartimento Clin Med Immunol & Malattie Infett, Med Clin 2, Sch Med, I-70124 Bari, Italy
关键词
D O I
10.3109/08923979809031510
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The recruitment of antigen-specific lymphocytes at liver site represents a prominent feature in patients chronically infected with hepatitis C virus (HCV). However, despite the strong and multispecific response, chronic infection leads in a significant number of cases to the development of cirrhosis and hepatocellular carcinoma. The finding that the expression of CD80 structure positively correlates with disease histological worsening points out a role far the costimulatory pathway in the progression of:liver cell injury. On the other hand, the demonstration of CD95 and CD95-ligand positive cells in the context of periportal areas, a pattern which is not strictly associated to HCV tissue distribution, indicates the occurrence of either virus-infected or innocent bystander hepatocyte killing. Nonetheless, the persistence of HCV, in spite of cytotoxic T lymphocyte (CTL) liver recruitment, suggests a possible in-situ imbalance of cytotoxic activities, above all referred to perforin-granzyme-dependent necrosis. Alltogether, these findings outline that several factors might be involved in HCV-driven immunopathogenesis. Therefore, the fully clarification of these mechanisms may offer a suitable therapeutical approach for the improvement of clinical outcome in chronic hepatitis C.
引用
收藏
页码:455 / 472
页数:18
相关论文
共 62 条
[1]  
Ando K, 1997, J IMMUNOL, V158, P5283
[2]  
BLAZAR BR, 1994, BLOOD, V83, P3815
[3]  
Bluestone JA, 1997, J IMMUNOL, V158, P1989
[4]   The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response [J].
Boussiotis, VA ;
Freeman, GJ ;
Gribben, JG ;
Nadler, LM .
IMMUNOLOGICAL REVIEWS, 1996, 153 :5-26
[5]   Cytotoxic T cells and viral hepatitis [J].
Chisari, FV .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1472-1477
[6]   Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection [J].
Corado, J ;
Toro, F ;
Rivera, H ;
Bianco, NE ;
Deibis, L ;
DeSanctis, JB .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (03) :451-457
[7]  
DELPRETE G, 1994, LAB INVEST, V70, P299
[8]   In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C [J].
Fiore, G ;
Angarano, I ;
Caccetta, L ;
Serrone, M ;
Jirillo, E ;
Schiraldi, O ;
Antonaci, S .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1997, 9 (05) :491-496
[9]  
Fiore G, 1997, MICROBIOS, V92, P73
[10]  
Fiore G, 1997, MED SCI RES, V25, P755